Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
45.23B | 50.20B | 45.52B | 37.55B | 30.37B | 34.30B | Gross Profit |
13.67B | 15.53B | 14.37B | 11.93B | 8.49B | 10.33B | EBIT |
3.97B | 6.13B | 5.60B | 4.08B | 1.91B | 2.59B | EBITDA |
6.02B | 8.59B | 7.15B | 5.71B | 3.38B | 3.92B | Net Income Common Stockholders |
2.71B | 4.56B | 4.03B | 2.89B | 1.46B | 1.58B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.21B | 11.89B | 12.65B | 12.33B | 4.92B | 3.40B | Total Assets |
67.64B | 60.16B | 55.10B | 47.51B | 35.05B | 34.16B | Total Debt |
8.88B | 9.36B | 6.38B | 5.48B | 10.25B | 13.27B | Net Debt |
-833.00M | -2.53B | -2.27B | -1.85B | 5.33B | 9.87B | Total Liabilities |
27.53B | 30.19B | 30.24B | 27.18B | 19.97B | 21.05B | Stockholders Equity |
40.11B | 29.98B | 24.86B | 20.33B | 15.08B | 13.11B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.09B | -486.00M | 10.50B | 5.07B | -1.16B | Operating Cash Flow |
0.00 | 929.00M | 2.68B | 11.67B | 5.92B | 23.00M | Investing Cash Flow |
0.00 | -3.63B | -3.08B | -1.55B | -919.00M | -1.16B | Financing Cash Flow |
0.00 | 1.24B | 406.00M | -3.15B | -3.69B | 245.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | $4.39B | 11.81 | 5.17% | 249.38% | 3.98% | -12.17% | |
64 Neutral | ¥25.43B | 11.65 | 4.09% | -4.49% | -36.44% | ||
$26.36B | 32.32 | 27.22% | 1.17% | ― | ― | ||
$1.48B | 19.48 | 4.82% | 3.47% | ― | ― | ||
€433.89M | 6.06 | 10.88% | 4.41% | ― | ― | ||
74 Outperform | ¥86.76B | 8.01 | 3.18% | 12.42% | 82.93% |